The preliminary safety results of an observational phase II study of concurrent use of aspirin with dabrafenib and trametinib in BRAF V600 NSCLC.
Authors: Rui Han, Jianghua Li, Yong He
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e20632
Source:
Full article
Abstract
e20632